GAD65 Autoantibody Responses in Japanese Latent Autoimmune Diabetes in Adult Patients
Open Access
- 1 August 2008
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 31 (8) , 1602-1607
Abstract
OBJECTIVE—To determine whether development of insulin requirement in patients with latent autoimmune diabetes in adults (LADA) is accompanied with the emergence of a type 1 diabetes–like autoimmune response. RESEARCH DESIGN AND METHODS—We correlated β-cell–specific autoimmunity reflected in autoantibodies to the 65-kDa isoform of GAD (GAD65) with insulin requirement. We determined GAD65Ab epitope specificities in type 1 diabetic patients, LADA patients without insulin requirement (nonprogressed), and LADA patients that had developed insulin requirement (progressed). RESULTS—Recognition of a type 1 diabetes–specific GAD65Ab epitope was more pronounced in type 1 diabetic patients than in nonprogressed (P < 0.001) or progressed (P < 0.01) LADA patients, with no significant differences between the two LADA cohorts. These differences were particularly pronounced in samples with GAD65Ab titers <1,000 units/ml, with no differences in epitope specificities in samples with higher GAD65Ab titers. Disease duration (initial diabetes diagnosis until sample collection or development of insulin requirement) in nonprogressed and progressed LADA patients, respectively, was not correlated with epitope specificity, suggesting lack of epitope maturation. This was supported by epitope analyses of longitudinal samples from LADA patients during progression to insulin requirement. CONCLUSIONS—First, the GAD65Ab-specific autoimmune reaction in type 1 diabetic patients with low and moderate GAD65Ab titers differs from that in LADA patients, irrespective of insulin requirement. Second, the GAD65Ab-specific autoimmune response in LADA patients does not change after their initial diabetes diagnosis. Finally, LADA patients with high GAD65Ab titers resemble type 1 diabetic patients in their GAD65Ab epitope specificity.Keywords
This publication has 21 references indexed in Scilit:
- COOH-Terminal Clustering of Autoantibody and T-Cell Determinants on the Structure of GAD65 Provide Insights Into the Molecular Basis of AutoreactivityDiabetes, 2008
- Autoantibody epitopes to the smaller isoform of glutamate decarboxylase do not differ in Swedish and Japanese type 1 diabetes patients and may be associated with high-risk human leucocyte antigen class II allelesClinical and Experimental Immunology, 2007
- GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77Diabetologia, 2007
- High Titer of Autoantibodies to GAD Identifies a Specific Phenotype of Adult-Onset Autoimmune DiabetesDiabetes Care, 2007
- Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) in prediabetic adults developing diabetesClinical and Experimental Immunology, 2007
- Latent autoimmune diabetes in adults (LADA) should be less latentDiabetologia, 2005
- Diabetes-related antibodies in adult diabetic patientsBest Practice & Research Clinical Endocrinology & Metabolism, 2005
- High-Titer Autoantibodies against Glutamic Acid Decarboxylase Plus Autoantibodies against Insulin and IA-2 Predicts Insulin Requirement in Adult Diabetic PatientsJournal of Autoimmunity, 1999
- Prediction of IDDM in the general population: strategies based on combinations of autoantibody markersDiabetes, 1997
- Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodiesDiabetes, 1996